Scott S. Billecke

3.2k total citations · 1 hit paper
30 papers, 2.6k citations indexed

About

Scott S. Billecke is a scholar working on Clinical Biochemistry, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Scott S. Billecke has authored 30 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Clinical Biochemistry, 10 papers in Physiology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Scott S. Billecke's work include Paraoxonase enzyme and polymorphisms (12 papers), Nitric Oxide and Endothelin Effects (7 papers) and Biochemical Acid Research Studies (6 papers). Scott S. Billecke is often cited by papers focused on Paraoxonase enzyme and polymorphisms (12 papers), Nitric Oxide and Endothelin Effects (7 papers) and Biochemical Acid Research Studies (6 papers). Scott S. Billecke collaborates with scholars based in United States, Israel and Japan. Scott S. Billecke's co-authors include Bert N. La Du, Robert C. Sorenson, Michael Aviram, Charles L. Bisgaier, Cary Hsu, Dragomir Draganov, Mira Rosenblat, Roger S. Newton, Catherine E. Watson and Philip L. Stetson and has published in prestigious journals such as Journal of Biological Chemistry, Free Radical Biology and Medicine and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Scott S. Billecke

30 papers receiving 2.5k citations

Hit Papers

Human serum paraoxonase (PON 1) is inactivated by oxidize... 1999 2026 2008 2017 1999 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott S. Billecke United States 20 1.8k 927 605 523 459 30 2.6k
S.L. Primo-Parmo United States 12 1.6k 0.9× 813 0.9× 446 0.7× 644 1.2× 291 0.6× 19 2.1k
Rebecca J. Richter United States 36 3.4k 1.9× 2.5k 2.7× 755 1.2× 944 1.8× 483 1.1× 57 4.7k
Mariann Harangi Hungary 23 548 0.3× 255 0.3× 166 0.3× 297 0.6× 279 0.6× 117 1.8k
Bharti Mackness United Kingdom 46 6.0k 3.4× 2.9k 3.2× 1.5k 2.5× 2.1k 4.1× 791 1.7× 93 7.8k
M Lakshman United States 31 275 0.2× 203 0.2× 273 0.5× 203 0.4× 921 2.0× 124 3.2k
Chan‐Sik Kim South Korea 29 748 0.4× 245 0.3× 73 0.1× 202 0.4× 673 1.5× 98 2.3k
Kleopatra H. Schulpis Greece 24 631 0.4× 121 0.1× 234 0.4× 182 0.3× 592 1.3× 145 2.0k
J.P. De La Cruz Spain 29 178 0.1× 110 0.1× 246 0.4× 236 0.5× 386 0.8× 125 2.6k
Hassan Ahmadvand Iran 24 138 0.1× 288 0.3× 118 0.2× 231 0.4× 358 0.8× 140 1.9k
Grażyna Wójcicka Poland 23 207 0.1× 123 0.1× 198 0.3× 127 0.2× 409 0.9× 65 1.8k

Countries citing papers authored by Scott S. Billecke

Since Specialization
Citations

This map shows the geographic impact of Scott S. Billecke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott S. Billecke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott S. Billecke more than expected).

Fields of papers citing papers by Scott S. Billecke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott S. Billecke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott S. Billecke. The network helps show where Scott S. Billecke may publish in the future.

Co-authorship network of co-authors of Scott S. Billecke

This figure shows the co-authorship network connecting the top 25 collaborators of Scott S. Billecke. A scholar is included among the top collaborators of Scott S. Billecke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott S. Billecke. Scott S. Billecke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chinnaiyan, Kavitha M., et al.. (2015). Feasibility of Establishing a Comprehensive Yoga Program and its Dose-Effect Relationship on Cardiovascular Risk Factors and Wellness Parameters: A Pilot Study. International Journal of Yoga Therapy. 25(1). 135–140. 2 indexed citations
2.
Billecke, Scott S., et al.. (2013). Injury or Activity-Related Pain Sustained by a Population of At-Risk Women during a 6-Month Exercise Program. The Physician and Sportsmedicine. 41(2). 7–14. 1 indexed citations
3.
Northcott, Carrie A., Scott S. Billecke, Teresa Craig, et al.. (2012). Nitric oxide synthase, ADMA, SDMA, and nitric oxide activity in the paraventricular nucleus throughout the etiology of renal wrap hypertension. American Journal of Physiology-Heart and Circulatory Physiology. 302(11). H2276–H2284. 8 indexed citations
4.
Franklin, Barry A. & Scott S. Billecke. (2012). Putting the Benefits and Risks of Aerobic Exercise in Perspective. Current Sports Medicine Reports. 11(4). 201–208. 33 indexed citations
5.
Billecke, Scott S. & Pamela A. Marcovitz. (2011). Aliskiren/amlodipine combination for the treatment of hypertension. Drugs of today. 47(6). 403–403. 3 indexed citations
7.
Marcovitz, Pamela A., et al.. (2010). Pheochromocytoma Presenting with Takotsubo Syndrome. Journal of Interventional Cardiology. 23(5). 437–442. 36 indexed citations
8.
Billecke, Scott S., Louis G. D’Alecy, Steven E. Whitesall, et al.. (2008). Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease. Nephrology Dialysis Transplantation. 24(2). 489–496. 21 indexed citations
9.
Teiber, John F., Scott S. Billecke, Bert N. La Du, & Dragomir Draganov. (2007). Estrogen esters as substrates for human paraoxonases. Archives of Biochemistry and Biophysics. 461(1). 24–29. 32 indexed citations
10.
Billecke, Scott S., et al.. (2006). Contribution of whole blood to the control of plasma asymmetrical dimethylarginine. American Journal of Physiology-Heart and Circulatory Physiology. 291(4). H1788–H1796. 35 indexed citations
11.
Whitesall, Steven E., et al.. (2005). Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats. American Journal of Physiology-Heart and Circulatory Physiology. 290(1). H209–H216. 39 indexed citations
12.
Kamada, Yasuhiko, et al.. (2004). Ubiquitination and Degradation of Neuronal Nitric-Oxide Synthase in Vitro: Dimer Stabilization Protects the Enzyme from Proteolysis. Molecular Pharmacology. 66(4). 964–969. 39 indexed citations
13.
Osawa, Yoichi, et al.. (2003). Proteolytic Degradation of Nitric Oxide Synthase: Effect of Inhibitors and Role of hsp90-Based Chaperones. Journal of Pharmacology and Experimental Therapeutics. 304(2). 493–497. 51 indexed citations
14.
Draganov, Dragomir, Philip L. Stetson, Catherine E. Watson, Scott S. Billecke, & Bert N. La Du. (2000). Rabbit Serum Paraoxonase 3 (PON3) Is a High Density Lipoprotein-associated Lactonase and Protects Low Density Lipoprotein against Oxidation. Journal of Biological Chemistry. 275(43). 33435–33442. 265 indexed citations
15.
Du, Bert N. La, Michael Aviram, Scott S. Billecke, et al.. (1999). On the physiological role(s) of the paraoxonases. Chemico-Biological Interactions. 119-120. 379–388. 157 indexed citations
16.
Sorenson, Robert C., Michael Aviram, Charles L. Bisgaier, et al.. (1999). Properties of the retained N-terminal hydrophobic leader sequence in human serum paraoxonase/arylesterase. Chemico-Biological Interactions. 119-120. 243–249. 15 indexed citations
17.
Billecke, Scott S., et al.. (1999). Characterization of a soluble mouse liver enzyme capable of hydrolyzing diisopropyl phosphorofluoridate. Chemico-Biological Interactions. 119-120. 251–256. 30 indexed citations
18.
Naguib, Mohamed, Abdulhamid H. Samarkandi, David R. Bevan, et al.. (1999). Increased Plasma Cholinesterase Activity and Mivacurium Resistance: Report of a Family. Anesthesia & Analgesia. 89(6). 1579–1579. 2 indexed citations
19.
Doorn, Jonathan A., Robert C. Sorenson, Scott S. Billecke, Cary Hsu, & Bert N. La Du. (1999). Evidence that several conserved histidine residues are required for hydrolytic activity of human paraoxonase/arylesterase. Chemico-Biological Interactions. 119-120. 235–241. 12 indexed citations
20.
Sorenson, Robert C., Charles L. Bisgaier, Michael Aviram, et al.. (1999). Human Serum Paraoxonase/Arylesterase’s Retained HydrophobicN-Terminal Leader Sequence Associates With HDLs by Binding Phospholipids. Arteriosclerosis Thrombosis and Vascular Biology. 19(9). 2214–2225. 266 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026